PURSENNID Safety Questions, PURSENNID Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about PURSENNID. Our extensive database of PURSENNID adverse events and PURSENNID warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about PURSENNID
PURSENNID Safety Reports
Total PURSENNID reports: 5.PURSENNID FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 3.
Take PURSENNID Side Effects Survey or Share Your PURSENNID Story. Read More Here.
Physician from JAPAN reported PURSENNID problem on Feb 26, 2007. Female patient, 86 years of age, was diagnosed with constipation, hyperkalaemia, hypertension, cardiac failure, reflux oesophagitis, insomnia and was treated with PURSENNID. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. PURSENNID dosage: unknown. During the same period patient was treated with ARGAMATE JELLY, COZAAR, ALDACTONE, LASIX, TAKEPRON, LENDORMIN, ZOLPIDEM TARTRATE. Patient died on 02/09/2007.
PURSENNID problem was reported by a Consumer or non-health professional from JAPAN on Aug 21, 2007. Female patient was treated with PURSENNID. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, malabsorption. PURSENNID dosage: unknown. Patient recovered.
Health Professional from JAPAN reported PURSENNID problem on Aug 24, 2007. Female patient was diagnosed with painful defaecation, nasopharyngitis, depression, insomnia and was treated with PURSENNID. After drug was administered, patient experienced the following problems/side effects: ileus. PURSENNID dosage: 24 MG. During the same period patient was treated with IBUPROFEN, ASTOMIN, ANAFRANIL, CERCINE, ZOLPIDEM TARTRATE, DEPAKENE. Patient was hospitalized. Patient recovered.
PURSENNID problem was reported by a Consumer or non-health professional from SWITZERLAND on Aug 20, 2007. Female patient, 79 years of age, was diagnosed with constipation and was treated with PURSENNID. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, inflammation, malaise, mucosal dryness, renal failure chronic, syncope. PURSENNID dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ITALY reported PURSENNID problem on Sept 05, 2007. Female patient, 61 years of age, weighting 128.1 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with PURSENNID. After drug was administered, patient experienced the following problems/side effects: chills, hyperhidrosis, hypertension, syncope, vomiting. PURSENNID dosage: unknown. During the same period patient was treated with NATEGLINIDE, VALSARTAN. Patient was hospitalized. Patient recovered.